Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹808.04 Cr |
| Fresh Issue | ₹627.00 Cr |
| Offer for Sale | ₹181.04 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹610.00-642.00 per share |
| Discount | Retail: 0.00,Employee: 0.00 |
| BSE Code | 543534 |
| NSE Code | AETHER |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | Kotak Mahindra Capital Co.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 23 shares and in multiples thereof
Incorporated in 2013, Aether Industries Limited is a manufacturer of speciality chemicals. The company is the sole manufacturer in India of chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone and Bifenthrin Alcohol.
The company has three business models: Large scale manufacturing of intermediates and speciality chemicals, CRAMS (contract research and manufacturing services) and Contract manufacturing.
Aether Industries has two manufacturing sites at Sachin in Surat, Gujarat. Manufacturing Facility 1 is a 3,500 square metre facility including R&D and Hydrogenation Facilities and Pilot Plant. Manufacturing Facility 2 encompasses roughly 10,500 square metres, with an installed capacity of 6,096 MT per year spread among three buildings and 16 production streams as of September 30, 2021.
As of March 31, 2022, Aether Industries Limited's product portfolio comprised over 25 products which were sold to over 34 global companies in 18 countries and to over 154 domestic companies. The company is the largest manufacturer of 4MEP, T2E, NODG and HEEP products in the world by volume.
Competitive Strengths
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for the Proposed Greenfield Project | 163.00 |
| 2 | Prepayment or Repayment of all or a portion of certain outstanding borrowings availed by the Company | 137.90 |
| 3 | Funding working capital requirements of the Company | 165.00 |
| 4 | General Corporate Purposes | 127.56 |
| Total | 593.46 |
| Period Ended | 31 Dec 2021 | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|---|
| Assets | 709.56 | 452.94 | 300.47 | 206.68 |
| Total Income | 449.32 | 453.79 | 303.78 | 203.28 |
| Profit After Tax | 82.90 | 71.12 | 39.96 | 23.34 |
| Amount in ₹ Crore | ||||
| KPI | |
|---|---|
| ROE | 40.79% |
| ROCE | 28.5% |
| Debt / Equity | 1.19% |
| RoNW | 40.79% |
| PAT Margin | 15.67% |
| EBITDA Margin | 24.93% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 7.36 | |
| P/E (x) | 72.3 | |
| Promoter Holding | 96.97% | 87.09% |
| Market Cap | ₹7991.79 Cr. | |
